Jeffrey Preston Bezos Executive Chairman of Amazon | Amazon
EVERSANA has announced the introduction of EVERSANA ORCHESTRATE MLR, a platform powered by artificial intelligence that aims to revolutionize the Medical, Legal, and Regulatory (MLR) process within the life sciences sector. This platform automates a substantial portion of tasks by employing a user-friendly and regulatory-compliant interface.
The creation of EVERSANA ORCHESTRATE MLR was based on Amazon’s Bedrock, a choice of highly effective foundation models. EVERSANA collaborated with Modus Create and Veeva for seamless integration with Veeva PromoMats. "EVERSANA ORCHESTRATE MLR is a game-changer for the life science industry," said Jim Lang, CEO of EVERSANA.
Traditionally, MLR review processes in organizations have been manual, involving meticulous examination of marketing materials against the latest regulatory claims. This new platform automates claim identification, extraction, and management, significantly speeding up the process. As a result, updates and reviews can be completed more quickly, reducing overall content review time by up to 50 percent.
The introduction of Amazon Bedrock into this platform provides life sciences companies with essential AI tools to alleviate administrative burdens. "Generative AI is transforming the life sciences industry," noted Dan Sheeran, general manager, Healthcare and Life Sciences, AWS.
As part of the EVERSANA ORCHESTRATE Operating System, the new solution ensures compliance, accuracy, and quality for MLR reviews, showing an 86 percent reduction in submission errors. With automation, the solution is scalable and could lead to a 35 percent cost saving for teams.
Piloted with several life sciences companies, EVERSANA ORCHESTRATE MLR exemplifies the company's use of AI to address complex issues in the healthcare industry.